Self-Destructing Injectors Market 2017 Share, Trend, Segmentation and Forecast to 2022

This report covers market characteristics, size and growth, segmentation, regional breakdowns, competitive landscape, market shares, trends and strategies

PUNE, INDIA, October 2, 2017 /EINPresswire.com/ — This report studies Self-Destructing Injectors in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Access Complete Report @ https://www.wiseguyreports.com/reports/2314903-global-self-destructing-injectors-market-professional-survey-report-2017

Koska
Shanghai Solve Medical Devices
Zhejiang YaXin Medical
Shandong Weigao Group
Ningbo Greetmed Medical

By types, the market can be split into

By Application, the market can be split into

Hospitals and Clinics
Home Care
Academic & Research Institutes and CROs

By Regions, this report covers (we can add the regions/countries as you want)

North America
China
Europe
Southeast Asia
Japan
India

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2314903-global-self-destructing-injectors-market-professional-survey-report-2017

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Self-Destructing Injectors Market Professional Survey Report 2017

1 Industry Overview of Self-Destructing Injectors

1.1 Definition and Specifications of Self-Destructing Injectors

1.1.1 Definition of Self-Destructing Injectors

1.1.2 Specifications of Self-Destructing Injectors

1.2 Classification of Self-Destructing Injectors

1.2.1

1.2.2

1.3 Applications of Self-Destructing Injectors

1.3.1 Hospitals and Clinics

1.3.2 Home Care

1.3.3 Academic & Research Institutes and CROs

1.4 Market Segment by Regions

1.4.1 North America

1.4.2 China

1.4.3 Europe

1.4.4 Southeast Asia

1.4.5 Japan

1.4.6 India

2 Manufacturing Cost Structure Analysis of Self-Destructing Injectors

2.1 Raw Material and Suppliers

2.2 Manufacturing Cost Structure Analysis of Self-Destructing Injectors

2.3 Manufacturing Process Analysis of Self-Destructing Injectors

2.4 Industry Chain Structure of Self-Destructing Injectors

3 Technical Data and Manufacturing Plants Analysis of Self-Destructing Injectors

3.1 Capacity and Commercial Production Date of Global Self-Destructing Injectors Major Manufacturers in 2016

3.2 Manufacturing Plants Distribution of Global Self-Destructing Injectors Major Manufacturers in 2016

3.3 R&D Status and Technology Source of Global Self-Destructing Injectors Major Manufacturers in 2016

3.4 Raw Materials Sources Analysis of Global Self-Destructing Injectors Major Manufacturers in 2016

4 Global Self-Destructing Injectors Overall Market Overview

4.1 2012-2017E Overall Market Analysis

4.2 Capacity Analysis

4.2.1 2012-2017E Global Self-Destructing Injectors Capacity and Growth Rate Analysis

4.2.2 2016 Self-Destructing Injectors Capacity Analysis (Company Segment)

4.3 Sales Analysis

4.3.1 2012-2017E Global Self-Destructing Injectors Sales and Growth Rate Analysis

4.3.2 2016 Self-Destructing Injectors Sales Analysis (Company Segment)

4.4 Sales Price Analysis

4.4.1 2012-2017E Global Self-Destructing Injectors Sales Price

4.4.2 2016 Self-Destructing Injectors Sales Price Analysis (Company Segment)

5 Self-Destructing Injectors Regional Market Analysis

5.1 North America Self-Destructing Injectors Market Analysis

5.1.1 North America Self-Destructing Injectors Market Overview

5.1.2 North America 2012-2017E Self-Destructing Injectors Local Supply, Import, Export, Local Consumption Analysis

5.1.3 North America 2012-2017E Self-Destructing Injectors Sales Price Analysis

5.1.4 North America 2016 Self-Destructing Injectors Market Share Analysis

5.2 China Self-Destructing Injectors Market Analysis

5.2.1 China Self-Destructing Injectors Market Overview

5.2.2 China 2012-2017E Self-Destructing Injectors Local Supply, Import, Export, Local Consumption Analysis

5.2.3 China 2012-2017E Self-Destructing Injectors Sales Price Analysis

5.2.4 China 2016 Self-Destructing Injectors Market Share Analysis

5.3 Europe Self-Destructing Injectors Market Analysis

5.3.1 Europe Self-Destructing Injectors Market Overview

5.3.2 Europe 2012-2017E Self-Destructing Injectors Local Supply, Import, Export, Local Consumption Analysis

5.3.3 Europe 2012-2017E Self-Destructing Injectors Sales Price Analysis

5.3.4 Europe 2016 Self-Destructing Injectors Market Share Analysis

5.4 Southeast Asia Self-Destructing Injectors Market Analysis

5.4.1 Southeast Asia Self-Destructing Injectors Market Overview

5.4.2 Southeast Asia 2012-2017E Self-Destructing Injectors Local Supply, Import, Export, Local Consumption Analysis

5.4.3 Southeast Asia 2012-2017E Self-Destructing Injectors Sales Price Analysis

5.4.4 Southeast Asia 2016 Self-Destructing Injectors Market Share Analysis

5.5 Japan Self-Destructing Injectors Market Analysis

5.5.1 Japan Self-Destructing Injectors Market Overview

5.5.2 Japan 2012-2017E Self-Destructing Injectors Local Supply, Import, Export, Local Consumption Analysis

5.5.3 Japan 2012-2017E Self-Destructing Injectors Sales Price Analysis

5.5.4 Japan 2016 Self-Destructing Injectors Market Share Analysis

5.6 India Self-Destructing Injectors Market Analysis

5.6.1 India Self-Destructing Injectors Market Overview

5.6.2 India 2012-2017E Self-Destructing Injectors Local Supply, Import, Export, Local Consumption Analysis

5.6.3 India 2012-2017E Self-Destructing Injectors Sales Price Analysis

5.6.4 India 2016 Self-Destructing Injectors Market Share Analysis

6 Global 2012-2017E Self-Destructing Injectors Segment Market Analysis (by Type)

6.1 Global 2012-2017E Self-Destructing Injectors Sales by Type

6.2 Different Types of Self-Destructing Injectors Product Interview Price Analysis

6.3 Different Types of Self-Destructing Injectors Product Driving Factors Analysis

6.3.1 Type I Self-Destructing Injectors Growth Driving Factor Analysis

6.3.2 Type II Self-Destructing Injectors Growth Driving Factor Analysis

……Continued

Purchase Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2314903

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

DOCTOR OF FRESH MED NYC at PHYSIO LOGIC NYC TO BECOME A CERTIFIED CHEF

The Physician Plans to Implement Certification in Prescribing Food as Medicine to Treat Patients

In my 15 years of practicing medicine, I’ve witnessed the impact of poor diets on our health. Being a chef allows me the opportunity to share the importance of food and cooking as medicine.”

— Dr. Robert Graham, MD of FRESH Med NYC at Physio Logic NYC

NEW YORK, NY, USA, October 2, 2017 /EINPresswire.com/ — FRESH Med NYC at Physio Logic NYC co-founder Robert E. Graham, MD, MPH, has embarked on the Chef Training Program at the Natural Gourmet Institute to become a certified chef. Once the program is completed on September 15, 2018, Dr. Graham plans to use his chef training to further his food-as-medicine based medical practice.

Dr. Graham’s decision to become a chef comes after years of seeing patients battling ailments that could be best remedied with a change of diet. “In my 15 years of practicing medicine, I’ve witnessed the impact of poor diets on our health. Being a chef allows me the opportunity to share the importance of food and cooking as medicine,” Dr. Robert Graham, MD of FRESH Med NYC at Physio Logic NYC.

It’s Dr. Graham’s belief that a doctor’s own health behavior is the greatest predictor of how they counsel their patients on a healthy behavior. He notes that “if doctors cook and learn about food, they are more likely to discuss the importance of healthy cooking and eating with their patients.”

A firm resister of “a pill for an ill”, Dr. Graham takes a "food first" approach to addressing health care needs by prescribing recipes along with meal plans consisting of whole foods and mostly vegetables. This is all a part of Dr. Graham’s mission to “put the health back in healthcare”.

Dr. Graham is no stranger to the food-as-medicine movement. Since 2010, Dr. Graham has been teaching doctors how to cook and in June 2013, he along with his wife Julie Graham started “Victory Greens,” the first educational and edible organic rooftop garden atop Lenox Hill Hospital in New York City. Thanks to Dr. Graham’s efforts, the cafeteria and patients are provided with fresh, organic produce in this unique “Rooftop to Bedside” service.

##MORE##

Interview opportunities are currently available with Dr. Graham. Feel free to contact Ashli Urquhart at ashli@auprnyc.com to schedule. For additional information on FRESH Med NYC at Physio Logic NYC, visit http://www.freshmednyc.com/

 
ABOUT DR. ROBERT GRAHAM

Dr. Graham is a Harvard trained physician, Board Certified in both Internal and Integrative Medicine and has over 15 years of clinical experience.  Dr. Graham received his medical degree from the School of Medicine at Stony Brook University Medical Center, Stony Brook, NY and completed his residency in Internal Medicine at Lenox Hill Hospital in New York City.

Dr. Graham received a Master’s of Public Health from the Harvard School of Public Health while completing three additional fellowships in General Internal Medicine and Complementary and Integrative Medical Therapies at Harvard Medical School as well as Medical Education at Mount Auburn Hospital in Cambridge, Massachusetts. He also completed course-work in Mind/Body Medicine, Positive Psychology, Lifestyle Medicine, Botanical and Traditional Chinese Medicine. Dr. Graham is recognized as a national leader in the fields of Complementary and Alternative/Integrative Medicine, culinary medicine, food, nutrition, urban farming, and in 2015 was a TEDxManhattan speaker.

ABOUT PHYSIO LOGIC

Physio Logic NYC is an integrated medical office and Pilates studio. The Brooklyn Heights-based clinic takes a modern approach on wellness by offering an integrated roster of over 40+ doctors, medical experts and Pilates instructors uniquely under one roof. The clinic’s world-renowned team of experts include Integrative Medicine, Integrative Spine & Sports Medicine Specialists, Anesthesiologists, Physical Therapists, Chiropractors, Nutritionists, Health Coaches, Acupuncturists, Massage Therapists, Rehab Technicians and Pilates Instructors.

Ashli Urquhart
Ashli Urquhart • Public Relations
323.547.4609
email us here


Source: EIN Presswire

Solutions into Aseptic Manufacturing and Patient Needs Through End-user Experience of Barts Health Pharmaceuticals

Pre-Filled Syringes Europe 2018

Pre-Filled Syringes Europe 2018

SMI REPORTS: Barts Health Pharmaceuticals present on formulation viscosity at SMi’s 10th Annual European Conference on Pre-Filled Syringes

LONDON, ENGLAND, UNITED KINGDOM, October 2, 2017 /EINPresswire.com/ — SMi Group will welcome the expertise of Orla Downes, Head of Business Development from Barts Health Pharmaceuticals, when she presents novel solutions into aseptic manufacturing next January at the 10th annual European conference on Pre-Filled Syringes in Central London.

With a focus on formulation viscosity, the talk will provide guidance on mitigating challenges during aseptic filling of viscous formulations in pre-filled syringes. Highlights from the presentation will also include answers to common user problems through human centred design with further insight into human factors. Trained as a Scientist, Orla has over 13 years' experience working in Aseptic Manufacturing and currently sits on the National Pharmacy Production Committee.

Other presenters on the notable speaker line-up at Pre-Filled Syringes Europe 2018 will include:

• Elizabeth Baker, Principal Pharmaceutical Officer Medical Drug Devi, MHRA
• Christian Dechant, Primary Packaging Director, Boehringer Ingelheim
• Dr. Stefan Holzner, Senior Director, Head of Device Development, Shire
• Bjorg Kaae Hunter, Device Engineering Manager, GSK
• Carsten Worsoe, Principal Scientist, Novo Nordisk
• Alphons Fakler, Group Head Risk Management, Biologics Technical Development and Manufacturing, Novartis
• Cedric Gysel, Staff Device Engineer, Janssen
• Vikas Jaitely, Senior Manager Pharmaceutical Sciences & CMC Regulatory Intelligence, Merck
• Sudeshna Dutta Ray, Senior Engineer Advanced Device Technology, Amgen
• Susanne Joerg, Head of Formulation Development, Lonza
• Markus Hemminger , Senior Engineer, F. Hoffmann-La Roche
• Barry Knight, Associate Director Devices, UCB Celltech
• Adrien Tisserand, Category Manager – Parenteral, Nemera
• Christa Jansen-Otten, Director, Prefillable Syringe Platform, West Pharmaceutical Services
• Kai Worrell, CEO, Worrell
• Oliver Valet, Co-Founder, rap.ID Particle Systems
• Stefan Heck, Business Development Manager, Intertek (Schweiz) AG
• Takeuchi Katsuyuki, Business Development – Global Pharmaceutical Solutions, Terumo Medical Corporation
• Takuya Minezaki , Research Manager, Mitsubishi Gas Chemical Company

SMi’s 10th annual 2018 Pre-Filled Syringes Europe conference and exhibition will take place on 17th & 18th Jan at the Copthorne Tara Hotel, Kensington, London UK.

Further information including a detailed agenda and full speaker line-up is available at www.pre-filled-syringes.com

— END —

Contact Information:

For media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
For all other enquires contact the team on Tel: +44 (0)20 7827 6000 or email events@smi-online.co.uk

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
Pre-Filled Syringes Europe 2018 is sponsored by Früh Verpackungstechnik AG, Intertek (Schweiz) AG, Mitsubishi Gas Chemical, Nemera, Nipro PharmaPackaging, Owen Mumford, Panasonic Healthcare, Terumo Pharmaceutical Solutions, West Pharmaceutical Services, Worrell, Inc.

Teri Arri
SMi Group
2078276000
email us here


Source: EIN Presswire

DRIVING OPTIMAL OUTCOMES IN CLINICAL TRIALS WITH INTEGRATED SUPPLY CHAIN: BSMA CONFERENCE, OCT 12 2017, FOSTER CITY, CA

Jim Benkendorf

Luke Moyer

Ravi Kiron

BSMA's 10th Annual Conference will address how collaboration for optimization at the head end of the supply chain is an imperative.

It was heartening to see so many of the attendees speak so highly of what you have accomplished for the Global Supply Chain space over the years and be their voice to enhance awareness and support….”

— Ravi Kiron, CEO, BIOPHARMA STRATEGY

CALABASAS, CALIFORNIA, USA, October 1, 2017 /EINPresswire.com/ — Foster City, California, September 27, 2017: Eminent executives of the bio-pharma industry will focus on how to meet the formidable challenges of drug development. A 2014 study done by the Tufts Center for the Study of Drug Development indicated that developing a new prescription medicine that gains marketing approval, a process often lasting more than a decade, is estimated to cost $2.6 billion. The 10th Annual Conference of BSMA on October 12, 2017 in Foster City, CA titled “DRIVING INNOVATIONS & TECHNOLOGY TRANSFORMING BIO-PHARMA”, will address how collaboration for optimization at the head end of the supply chain is an imperative. Technology enablers and service providers are facilitating the adoption of disruptive technologies of digital, Internet, data analytics and artificial intelligence to reduce cost of medicine and time to market. For details of the conference program, Click Here.

HIGHLIGHTS:
“Outsourcing the Clinical Supply Chain: Is a Single Provider Strategy the Solution?”
Under pressure to jumpstart productivity and reduce the time and cost of shepherding new drugs from laboratory through licensure, the biopharmaceutical industry began globalizing clinical trials about 15 years ago. This continued globalization has precipitated a spike in the operational and strategic obstacles faced by clinical trial professionals. Outsourcing models are discussed – multiple vendors versus single provider, with case study examples and guidance on top tips for success. The critical challenges faced by startup, small and mid-sized companies will also be addressed.
Jim Benkendorf, General Manager, Fisher Clinical Services

“Navigating the ASIA-PACIFIC Clinical Supply Chain for Accelerated & Efficient Drug Development”
Representing 60% of the world’s population, Asia continues to rise to the forefront of the clinical trial arena with an estimated 25% of global clinical trials taking place in Asian countries. The presentation will highlight unique clinical supply chain challenges and strategies required to achieve success for the conduct of trials in this varied and nuanced regulatory landscape.
Luke Moyer, Supply Chain Solutions Manager, Almac

"Integrating Planning and Logistics to Maximize Effectiveness of Clinical Trials Through a Data-driven, Systems Approach"
Solutions of Information Technology drive the holy grail of clinical supply chain which ties all stakeholders together for speed to market, improved outcomes of clinical trials and cost efficiency. This panel will address how operations planning, information systems, business practices and collaboration are improving the outcomes, accountability and visibility in the supply chain consisting of clinical operations and clinical supply with trials management and 3rd party service providers. Topics covered will include patient enrollment forecasting and real time updating, managing inventory with MRP and performing drug accountability and reconciliation, including returns.

PANEL:
• Bill Coakley, Senior Director, Global Supply Chain, BioMarin
• Kevin Shea, Senior Label Program Director, Clintrak Clinical Labeling
• Moderator: Ravi Kiron, Head, BioPharma External Innovation West Coast, EMD Serono

Conference Overview:
Since the inception of BSMA ten years ago, the conference has been recognized to be the most informative, interactive, technology-enabling and solution-sharing event in the bio-pharma space where drug manufacturers lead, academia provides research, and service providers build the extended supply chain. The collaboration with Biocom, Biomedical Manufacturing Network, the City of Fremont, CSCMP and the Keck Graduate Institute, is driven by the mission to empower small and mid-sized companies to further the resurgence of manufacturing in California.

Devendra Mishra
Bio Supply Management Alliance
760-822-7467
email us here

BSMA Launches in Boston, 2017


Source: EIN Presswire